Plant-Based Vaccines Global Market Report 2025

Description

Plant-based vaccines are recombinant vaccines that utilize antigens against specific infections incorporated into selected plants. These vaccines offer an effective means of treating various human and animal diseases.

The primary types of plant-based vaccines include bacterial vaccines, viral vaccines, parasite vaccines, and others. Bacterial vaccines involve preparations of either dead or weakened bacteria utilized as active immunizing agents. Various plant sources, including tobacco plants, maize, and potatoes, are employed for this purpose. Plant-based vaccines find applications in addressing diseases such as influenza, Zika virus, Ebola virus, poultry diseases, and others.

The plant-based vaccines market research report is one of a series of new reports from The Business Research Company that provides plant-based vaccines market statistics, including plant-based vaccines industry global market size, regional shares, competitors with a plant-based vaccines market share, detailed plant-based vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the plant-based vaccines industry. This plant-based vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based vaccines market size has grown rapidly in recent years. It will grow from $1.66 billion in 2024 to $1.83 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to traditional vaccine production challenges, need for cost-effective vaccine production, emergence of plant molecular farming, reduced allergenic potential, synthetic biology applications

The plant-based vaccines market size is expected to see rapid growth in the next few years. It will grow to $2.79 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to pandemic preparedness, global health security, expansion of vaccine applications, pharmaceutical industry adoption. Major trends in the forecast period include technological advancements in plant biotechnology, environmental sustainability, integration of artificial intelligence, and integration of ML.

The high prevalence of infectious diseases is expected to drive the growth of the plant-based vaccine market in the future. Infectious diseases are illnesses caused by germs, such as bacteria, viruses, fungi, or parasites. Plant-based vaccines, used in both traditional and modern medicine for various conditions, including infectious diseases, can offer safe, effective, stable, and affordable options for prophylactics, vaccines, and treatments. For instance, in October 2022, according to the Global Tuberculosis Report by the World Health Organization, a Switzerland-based global health agency, the global incidence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 population. TB cases were predominantly reported in the Southeast Asia region, accounting for 45% of the total, followed by Africa with 23%. Therefore, the high prevalence of infectious diseases is fueling the growth of the plant-based vaccine market.

The rising demand for personalized medicine is also expected to contribute to the growth of the plant-based vaccine market going forward. Personalized medicine tailors medical treatments to an individual's unique genetic makeup, providing more effective and precise healthcare solutions. Plant-based vaccines play a role in personalized medicine by allowing treatments to be customized based on individual genetic profiles, potentially offering safer and more effective immunotherapies by adapting vaccine components to specific patient needs and responses. For example, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), and of the 35 therapeutic NMEs, around 34% (or 12) were classified as personalized medicines by the PMC. Therefore, the growing demand for personalized medicine is driving the expansion of the plant-based vaccine market.

Government funding for vaccine development is expected to further propel the growth of the plant-based vaccine market. Government funding refers to the investment that supports specific industries to advance various aspects. Numerous government agencies are financing vaccine development efforts, including for COVID-19 vaccines, which aids in the creation of different types of vaccines, including plant-based COVID-19 vaccines. For instance, in November 2022, the U.S. Department of Health and Human Services (HHS), a US-based government agency, launched a new $350 million initiative to support HRSA-backed health centers in boosting COVID-19 vaccination efforts. This funding enables health centers to develop COVID-19 vaccines through mobile, drive-up, walk-up, or community-based vaccination events and collaborate with community organizations and other efforts to increase vaccine administration.

Product innovation is a key trend gaining traction in the plant-based vaccine market. Leading companies in this sector are focused on developing innovative products to maintain their market position. For example, in February 2022, Medicago Inc., a Canada-based biopharmaceutical company, and GSK PLC, a UK-based pharmaceutical and biotechnology company, announced that Health Canada had approved COVIFENZ, a COVID-19 vaccine. COVIFENZ is the first plant-based virus-like particles (VLP), recombinant, adjuvanted vaccine available for COVID-19. It utilizes COVID-19-like particle (CoVLP) technology and consists of recombinant spike (S) glycoproteins produced as VLPs.

Major companies in the plant-based vaccine market are focusing on advanced solutions such as plant-technology platforms to optimize production scalability, improve vaccine efficacy, and streamline cost-effective manufacturing. Plant-technology platforms leverage plant systems to efficiently produce vaccines and therapeutic proteins. For instance, in January 2022, British American Tobacco, a UK-based consumer goods company, launched KBio Holdings Limited (KBio), a biotech company aimed at accelerating the research, development, and production of novel treatments. KBio is focused on treatments for rare and infectious diseases, harnessing both the plant-based technology platform and its existing clinical and pre-clinical vaccines and antibody pipeline. The plant-based production system offers potential benefits such as greater speed, scalability, and thermostability.

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plant-based vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based vaccines market consists of sales of cholera vaccines and norovirus vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plant-based vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plant-based vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Vaccine Type: Bacterial Vaccines; Viral Vaccines; Parasite Vaccines; Other Vaccine Types
2) By Source: Tobacco Plant; Maize; Potato; Other Sources
3) By Application: Influenza; Zika Virus; Ebola Virus; Poultry Disease; Other Applications
Subsegments:
1) By Bacterial Vaccines: Recombinant Bacterial Vaccines; Conjugate Bacterial Vaccines; DNA-Based Bacterial Vaccines
2) By Viral Vaccines: Inactivated Viral Vaccines; Live Attenuated Viral Vaccines; Subunit Viral Vaccines
3) By Parasite Vaccines: Recombinant Parasite Vaccines; DNA-Based Parasite Vaccines
4) By Other Vaccine Types: Fungal Vaccines; Multivalent Vaccines; Toxin-Based Vaccines
Companies Mentioned: Sanofi Pasteur SA; GlaxoSmithKline plc.; British American Tobacco PLC; ICON Plc.; Agenus Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25216

1. Executive Summary

2. Plant-Based Vaccines Market Characteristics

3. Plant-Based Vaccines Market Trends And Strategies

4. Plant-Based Vaccines Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Plant-Based Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Plant-Based Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Plant-Based Vaccines Market Growth Rate Analysis
5.4. Global Plant-Based Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Plant-Based Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Plant-Based Vaccines Total Addressable Market (TAM)

6. Plant-Based Vaccines Market Segmentation

6.1. Global Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial Vaccines
Viral Vaccines
Parasite Vaccines
Other Vaccine Types
6.2. Global Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tobacco Plant
Maize
Potato
Other Sources
6.3. Global Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Influenza
Zika Virus
Ebola Virus
Poultry Disease
Other Applications
6.4. Global Plant-Based Vaccines Market, Sub-Segmentation Of Bacterial Vaccines, By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Bacterial Vaccines
Conjugate Bacterial Vaccines
DNA-Based Bacterial Vaccines
6.5. Global Plant-Based Vaccines Market, Sub-Segmentation Of Viral Vaccines, By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Viral Vaccines
Live Attenuated Viral Vaccines
Subunit Viral Vaccines
6.6. Global Plant-Based Vaccines Market, Sub-Segmentation Of Parasite Vaccines, By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Parasite Vaccines
DNA-Based Parasite Vaccines
6.7. Global Plant-Based Vaccines Market, Sub-Segmentation Of Other Vaccine Types, By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fungal Vaccines
Multivalent Vaccines
Toxin-Based Vaccines

7. Plant-Based Vaccines Market Regional And Country Analysis

7.1. Global Plant-Based Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Plant-Based Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plant-Based Vaccines Market

8.1. Asia-Pacific Plant-Based Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plant-Based Vaccines Market

9.1. China Plant-Based Vaccines Market Overview
9.2. China Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plant-Based Vaccines Market

10.1. India Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plant-Based Vaccines Market

11.1. Japan Plant-Based Vaccines Market Overview
11.2. Japan Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plant-Based Vaccines Market

12.1. Australia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plant-Based Vaccines Market

13.1. Indonesia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plant-Based Vaccines Market

14.1. South Korea Plant-Based Vaccines Market Overview
14.2. South Korea Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plant-Based Vaccines Market

15.1. Western Europe Plant-Based Vaccines Market Overview
15.2. Western Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plant-Based Vaccines Market

16.1. UK Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plant-Based Vaccines Market

17.1. Germany Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plant-Based Vaccines Market

18.1. France Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plant-Based Vaccines Market

19.1. Italy Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plant-Based Vaccines Market

20.1. Spain Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plant-Based Vaccines Market

21.1. Eastern Europe Plant-Based Vaccines Market Overview
21.2. Eastern Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plant-Based Vaccines Market

22.1. Russia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plant-Based Vaccines Market

23.1. North America Plant-Based Vaccines Market Overview
23.2. North America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plant-Based Vaccines Market

24.1. USA Plant-Based Vaccines Market Overview
24.2. USA Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plant-Based Vaccines Market

25.1. Canada Plant-Based Vaccines Market Overview
25.2. Canada Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plant-Based Vaccines Market

26.1. South America Plant-Based Vaccines Market Overview
26.2. South America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plant-Based Vaccines Market

27.1. Brazil Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plant-Based Vaccines Market

28.1. Middle East Plant-Based Vaccines Market Overview
28.2. Middle East Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plant-Based Vaccines Market

29.1. Africa Plant-Based Vaccines Market Overview
29.2. Africa Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plant-Based Vaccines Market Competitive Landscape And Company Profiles

30.1. Plant-Based Vaccines Market Competitive Landscape
30.2. Plant-Based Vaccines Market Company Profiles
- 30.2.1. Sanofi Pasteur SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. British American Tobacco PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. ICON Plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Agenus Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Plant-Based Vaccines Market Other Major And Innovative Companies

31.1. Medicago Inc.
31.2. Panacea Biotec Limited
31.3. Creative Biolabs Inc.
31.4. InVitria
31.5. Fraunhofer USA Inc.
31.6. Biodextris Inc.
31.7. Intravacc B.V
31.8. Avesthagen Limited
31.9. Calyxt Inc.
31.10. Zyus Life Sciences Inc.
31.11. Mapp Biopharmaceutical Inc.
31.12. Kentucky BioProcessing Inc.
31.13. Planet Biotechnology Inc.
31.14. Icon Genetics GmbH
31.15. PlantForm Corporation

32. Global Plant-Based Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plant-Based Vaccines Market

34. Recent Developments In The Plant-Based Vaccines Market

35. Plant-Based Vaccines Market High Potential Countries, Segments and Strategies

35.1 Plant-Based Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Plant-Based Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Plant-Based Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer